Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp

by | Sep 3, 2026 | Clinical Trials | 0 comments

​ Conditions: Uveal Melanoma, Metastatic

Interventions: Drug: Dexamethasone

Sponsors: University of California, San Diego; Immunocore Ltd

Not yet recruiting Conditions: Uveal Melanoma, Metastatic
Interventions: Drug: Dexamethasone
Sponsors: University of California, San Diego; Immunocore Ltd
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *